Despite early studies on myostatin indicating an increase of its serum concentration in heart failure (HF) [164,165], research by Furihata et al., found lower serum concentration of myostatin along with higher levels of its inhibitor—follistatin—in patients with HF [83]. This evidence concerns the gene MSTN and heart failure.